Parvovirus B19 in HIV infection: A treatable cause of anemia

Andrew Fuller; Len Moaven; Denis Spelman; W. John Spicer; Howard Wraight; David Curtis; Jenny Leydon; Jennifer Doultree; Stephen Locarnini

doi:10.1080/00313029600169154

Parvovirus B19 in HIV infection: A treatable cause of anemia

Andrew Fuller, Len Moaven, Denis Spelman, W. John Spicer, Howard Wraight, David Curtis, Jenny Leydon, Jennifer Doultree, Stephen Locarnini

Research output: Contribution to journal › Article › Research › peer-review

Abstract

We describe the case of an adult male patient with AIDS who presented with severe anemia and on investigation was found to have red cell aplasia due to parvovirus B19 infection. Bone marrow examination revealed absence of erythroid development and rare giant pronormoblasts. Repeated serological examinations revealed a low level of parvovirus IgM but no IgG. Viremia was demonstrated by electron microscopy and by the polymerase chain reaction (PCR). The patient's initial hemoglobin was 45 g/l and over a four month period he required twenty units of blood. He was treated with intravenous immunoglobulin (Intragam, CSL) at a dose of 400 mg/kg/day for five days. This led to an increase in his hemoglobin to 135 g/l. Parvovirus remained detectable by PCR but not by electron microscopy. Six months later the patient relapsed (Hb 65 g/l). Again he was transfused and treated with intravenous immunoglobulin for five days. His hemoglobin rose to 153 g/l and remained stable. He subsequently received maintenance treatment with 30 g of intagram once a month. We recommend that parvovirus be considered in any HIV infected patient with recurrent anemia.

Original language	English
Pages (from-to)	277-280
Number of pages	4
Journal	Pathology
Volume	28
Issue number	3
DOIs	https://doi.org/10.1080/00313029600169154
Publication status	Published - 1996
Externally published	Yes

Keywords

AIDS
Immunoglobulin
Parvovirus B19
Red cell aplasia

Cite this

Fuller, A., Moaven, L., Spelman, D., Spicer, W. J., Wraight, H., Curtis, D., ... Locarnini, S. (1996). Parvovirus B19 in HIV infection: A treatable cause of anemia. Pathology, 28(3), 277-280. https://doi.org/10.1080/00313029600169154

Fuller, Andrew ; Moaven, Len ; Spelman, Denis ; Spicer, W. John ; Wraight, Howard ; Curtis, David ; Leydon, Jenny ; Doultree, Jennifer ; Locarnini, Stephen. / Parvovirus B19 in HIV infection : A treatable cause of anemia. In: Pathology. 1996 ; Vol. 28, No. 3. pp. 277-280.

@article{1d4d2417f4e24a458ac9763ac575bc7a,

title = "Parvovirus B19 in HIV infection: A treatable cause of anemia",

abstract = "We describe the case of an adult male patient with AIDS who presented with severe anemia and on investigation was found to have red cell aplasia due to parvovirus B19 infection. Bone marrow examination revealed absence of erythroid development and rare giant pronormoblasts. Repeated serological examinations revealed a low level of parvovirus IgM but no IgG. Viremia was demonstrated by electron microscopy and by the polymerase chain reaction (PCR). The patient's initial hemoglobin was 45 g/l and over a four month period he required twenty units of blood. He was treated with intravenous immunoglobulin (Intragam, CSL) at a dose of 400 mg/kg/day for five days. This led to an increase in his hemoglobin to 135 g/l. Parvovirus remained detectable by PCR but not by electron microscopy. Six months later the patient relapsed (Hb 65 g/l). Again he was transfused and treated with intravenous immunoglobulin for five days. His hemoglobin rose to 153 g/l and remained stable. He subsequently received maintenance treatment with 30 g of intagram once a month. We recommend that parvovirus be considered in any HIV infected patient with recurrent anemia.",

keywords = "AIDS, Immunoglobulin, Parvovirus B19, Red cell aplasia",

author = "Andrew Fuller and Len Moaven and Denis Spelman and Spicer, {W. John} and Howard Wraight and David Curtis and Jenny Leydon and Jennifer Doultree and Stephen Locarnini",

year = "1996",

doi = "10.1080/00313029600169154",

language = "English",

volume = "28",

pages = "277--280",

journal = "Pathology",

issn = "0031-3025",

publisher = "Lippincott Williams & Wilkins",

number = "3",

}

Fuller, A, Moaven, L, Spelman, D , Spicer, WJ, Wraight, H, Curtis, D, Leydon, J, Doultree, J & Locarnini, S 1996, 'Parvovirus B19 in HIV infection: A treatable cause of anemia' Pathology, vol. 28, no. 3, pp. 277-280. https://doi.org/10.1080/00313029600169154

Parvovirus B19 in HIV infection : A treatable cause of anemia. / Fuller, Andrew; Moaven, Len; Spelman, Denis ; Spicer, W. John; Wraight, Howard; Curtis, David; Leydon, Jenny; Doultree, Jennifer; Locarnini, Stephen.

In: Pathology, Vol. 28, No. 3, 1996, p. 277-280.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Parvovirus B19 in HIV infection

T2 - A treatable cause of anemia

AU - Fuller, Andrew

AU - Moaven, Len

AU - Spelman, Denis

AU - Spicer, W. John

AU - Wraight, Howard

AU - Curtis, David

AU - Leydon, Jenny

AU - Doultree, Jennifer

AU - Locarnini, Stephen

PY - 1996

Y1 - 1996

N2 - We describe the case of an adult male patient with AIDS who presented with severe anemia and on investigation was found to have red cell aplasia due to parvovirus B19 infection. Bone marrow examination revealed absence of erythroid development and rare giant pronormoblasts. Repeated serological examinations revealed a low level of parvovirus IgM but no IgG. Viremia was demonstrated by electron microscopy and by the polymerase chain reaction (PCR). The patient's initial hemoglobin was 45 g/l and over a four month period he required twenty units of blood. He was treated with intravenous immunoglobulin (Intragam, CSL) at a dose of 400 mg/kg/day for five days. This led to an increase in his hemoglobin to 135 g/l. Parvovirus remained detectable by PCR but not by electron microscopy. Six months later the patient relapsed (Hb 65 g/l). Again he was transfused and treated with intravenous immunoglobulin for five days. His hemoglobin rose to 153 g/l and remained stable. He subsequently received maintenance treatment with 30 g of intagram once a month. We recommend that parvovirus be considered in any HIV infected patient with recurrent anemia.

AB - We describe the case of an adult male patient with AIDS who presented with severe anemia and on investigation was found to have red cell aplasia due to parvovirus B19 infection. Bone marrow examination revealed absence of erythroid development and rare giant pronormoblasts. Repeated serological examinations revealed a low level of parvovirus IgM but no IgG. Viremia was demonstrated by electron microscopy and by the polymerase chain reaction (PCR). The patient's initial hemoglobin was 45 g/l and over a four month period he required twenty units of blood. He was treated with intravenous immunoglobulin (Intragam, CSL) at a dose of 400 mg/kg/day for five days. This led to an increase in his hemoglobin to 135 g/l. Parvovirus remained detectable by PCR but not by electron microscopy. Six months later the patient relapsed (Hb 65 g/l). Again he was transfused and treated with intravenous immunoglobulin for five days. His hemoglobin rose to 153 g/l and remained stable. He subsequently received maintenance treatment with 30 g of intagram once a month. We recommend that parvovirus be considered in any HIV infected patient with recurrent anemia.

KW - AIDS

KW - Immunoglobulin

KW - Parvovirus B19

KW - Red cell aplasia

UR - http://www.scopus.com/inward/record.url?scp=0030431071&partnerID=8YFLogxK

U2 - 10.1080/00313029600169154

DO - 10.1080/00313029600169154

M3 - Article

VL - 28

SP - 277

EP - 280

JO - Pathology